Literature DB >> 28091969

Quality of life as predictor for the development of cardiac ischemia in high-risk asymptomatic diabetic patients.

Philip Haaf1, Myriam Ritter1, Leticia Grize2, Matthias E Pfisterer1, Michael J Zellweger3.   

Abstract

BACKGROUND: Ischemia induced by psychological stress and depression is a common phenomenon in stable coronary artery disease (CAD). We evaluated the quality of life (QoL) of diabetic patients screened for CAD and assessed the prognostic value of mental and physical QoL scores to predict the development of new cardiac ischemia.
METHODS: Prospective multicentre outcome study. The study comprised 400 asymptomatic diabetic patients without history or symptoms of CAD. They underwent myocardial perfusion single-photon emission computed tomography (MPS) and assessment of QoL by two questionnaires: Hospital Depression and Anxiety Scale (HADS-D and HADS-A) and Medical Outcomes Study Short Form 36 (SF-36) at baseline and after 2 years. Patients with normal MPS received usual care; those with abnormal MPS received medical or combined invasive and medical management.
RESULTS: Only mental QoL scores but not physical QoL scores or traditional cardiovascular risk factors were predictive of new ischemia (n = 11/306) during follow-up. The prognostic value for new ischemia as quantified by the area under the receiver operating characteristics curve (AUC) amounted to 0.784 (95% confidence interval (CI) 0.654-0.914, P = 0.002) for HADS-D and to 0.737 (95% CI 0.580-0.893, P = 0.011) for HADS-A. This finding was confirmed by SF-36 mental sum score (AUC 0.688, 95% CI 0.539-0.836, P = 0.036), but not SF-36 physical sum score. QoL scores did not change after 2 years in patients with ischemia at baseline.
CONCLUSIONS: QoL scores assessing mental health, particularly depression and anxiety, predicted the development of new cardiac ischemia in asymptomatic diabetic patients. The study is limited by a small number of events (new ischemia) and so the results should be considered hypothesis generating rather than conclusive.

Entities:  

Keywords:  Quality of life; diabetes; myocardial perfusion scintigraphy; silent cardiac ischemia

Mesh:

Year:  2017        PMID: 28091969     DOI: 10.1007/s12350-016-0759-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  33 in total

1.  ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Peter J Grant; Stefan D Anker; Christian Berne; Francesco Cosentino; Nicolas Danchin; Christi Deaton; Javier Escaned; Hans-Peter Hammes; Heikki Huikuri; Michel Marre; Nikolaus Marx; Linda Mellbin; Jan Ostergren; Carlo Patrono; Petar Seferovic; Miguel Sousa Uva; Marja-Riita Taskinen; Michal Tendera; Jaakko Tuomilehto; Paul Valensi; Jose Luis Zamorano; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Guy De Backer; Per Anton Sirnes; Eduardo Alegria Ezquerra; Angelo Avogaro; Lina Badimon; Elena Baranova; Helmut Baumgartner; John Betteridge; Antonio Ceriello; Robert Fagard; Christian Funck-Brentano; Dietrich C Gulba; David Hasdai; Arno W Hoes; John K Kjekshus; Juhani Knuuti; Philippe Kolh; Eli Lev; Christian Mueller; Ludwig Neyses; Peter M Nilsson; Joep Perk; Piotr Ponikowski; Zeljko Reiner; Naveed Sattar; Volker Schächinger; André Scheen; Henrik Schirmer; Anna Strömberg; Svetlana Sudzhaeva; Juan Luis Tamargo; Margus Viigimaa; Charalambos Vlachopoulos; Robert G Xuereb
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

Review 2.  Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease.

Authors:  Jingkai Wei; Cherie Rooks; Ronnie Ramadan; Amit J Shah; J Douglas Bremner; Arshed A Quyyumi; Michael Kutner; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2014-05-01       Impact factor: 2.778

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.

Authors:  J Juenger; D Schellberg; S Kraemer; A Haunstetter; C Zugck; W Herzog; M Haass
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

5.  Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction.

Authors:  R C Ziegelstein; J A Fauerbach; S S Stevens; J Romanelli; D P Richter; D E Bush
Journal:  Arch Intern Med       Date:  2000-06-26

Review 6.  Quality of life and diabetes.

Authors:  R R Rubin; M Peyrot
Journal:  Diabetes Metab Res Rev       Date:  1999 May-Jun       Impact factor: 4.876

7.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

8.  Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy.

Authors:  L Gorkin; N K Norvell; R C Rosen; E Charles; S A Shumaker; K M McIntyre; R J Capone; J Kostis; R Niaura; P Woods
Journal:  Am J Cardiol       Date:  1993-05-01       Impact factor: 2.778

9.  Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.

Authors:  Michael J Zellweger; Michael Maraun; Hans H Osterhues; Ulrich Keller; Jan Müller-Brand; Raban Jeger; Otmar Pfister; Thilo Burkard; Friedrich Eckstein; Stefanie von Felten; Stefan Osswald; Matthias Pfisterer
Journal:  JACC Cardiovasc Imaging       Date:  2014-09-17

10.  Depression and cardiac disease: epidemiology, mechanisms, and diagnosis.

Authors:  Jeff C Huffman; Christopher M Celano; Scott R Beach; Shweta R Motiwala; James L Januzzi
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-04-07
View more
  3 in total

1.  The interface of emotion and biology in myocardial ischemia: Can we progress using the traditional paradigm?

Authors:  Robert Soufer; Matthew M Burg
Journal:  J Nucl Cardiol       Date:  2017-02-02       Impact factor: 5.952

2.  Intensification of functional neural control on heartbeat dynamics in subclinical depression.

Authors:  Claudio Gentili; Gaetano Valenza; Vincenzo Catrambone; Simone Messerotti Benvenuti
Journal:  Transl Psychiatry       Date:  2021-04-14       Impact factor: 6.222

Review 3.  Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease.

Authors:  Mengmeng Zhu; Yiwen Li; Binyu Luo; Jing Cui; Yanfei Liu; Yue Liu
Journal:  Front Cardiovasc Med       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.